AAAAAA
Results: 26-37/37
Authors:
GEORGES C
VERGERON H
SHARIF M
SAXNE T
AYRAL X
LISTRAT V
RAVAUD P
DIEPPE P
DOUGADOS M
Citation: C. Georges et al., SERUM BIOLOGICAL MARKERS AND PROGRESSION OF KNEE OSTEOARTHRITIS, Arthritis and rheumatism, 39(9), 1996, pp. 876-876
Authors:
RAVAUD P
THEPOT C
AULELEY GR
AMOR B
Citation: P. Ravaud et al., IMAGING IN MULTIPLE-MYELOMA, Annales de medecine interne, 147(8), 1996, pp. 570-575
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
LEBLOND V
DIVINE M
DREYFUS F
BELANGER C
TROUSSARD X
MARIETTE X
BROUET JC
Citation: Jp. Fermand et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL INVOLVING 167 PATIENTS, Stem cells, 13, 1995, pp. 156-159
Authors:
DREYFUS F
RIBRAG V
LEBLOND V
RAVAUD P
MELLE J
QUARRE MC
PILLIER C
BOCCACCIO C
VARET B
Citation: F. Dreyfus et al., DETECTION OF MALIGNANT B-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS AFTER CHEMOTHERAPY IN PATIENTS WITH MULTIPLE-MYELOMA, Bone marrow transplantation, 15(5), 1995, pp. 707-711
Authors:
DURIEUX P
RAVAUD P
Citation: P. Durieux et P. Ravaud, EVALUATION OF MEDICAL-PRACTICE IN RADIOLO GY, Journal de radiologie, 76(11), 1995, pp. 1009-1012
Authors:
LOPEZ S
HALBWACHSMECARELLI L
RAVAUD P
BESSOU G
DOUGADOS M
PORTEU F
Citation: S. Lopez et al., NEUTROPHIL EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS (TNF-R) AND OF ACTIVATION MARKERS (CD11B, CD43, CD63) IN RHEUMATOID-ARTHRITIS, Clinical and experimental immunology, 101(1), 1995, pp. 25-32
Authors:
MARIETTE X
BERGOT C
RAVAUD P
ROUX C
LAVALJEANTET M
BROUET JC
FERMAND JP
Citation: X. Mariette et al., EVOLUTION OF BONE DENSITOMETRY IN PATIENTS WITH MYELOMA TREATED WITH CONVENTIONAL OR INTENSIVE THERAPY, Cancer, 76(9), 1995, pp. 1559-1563
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
DIVINE M
LEBLOND V
BELANGER C
DREYFUS F
TROUSSARD X
BRECHIGNAC S
MARIETTE X
BROUET IC
Citation: Jp. Fermand et al., HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT) VERSUS CONVENTIONAL CHEMOTHERAPY WITH HDT RESCUE IN MULTIPLE-MYELOMA (MM) - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL, Blood, 86(10), 1995, pp. 808-808
Authors:
ROUX C
RAVAUD P
COHENSOLAL M
DEVERNEJOUL MC
GUILLEMANT S
CHERRUAU B
DELMAS P
DOUGADOS M
AMOR B
Citation: C. Roux et al., BIOLOGIC, HISTOLOGIC AND DENSITOMETRIC EFFECTS OF ORAL RISEDRONATE ONBONE IN PATIENTS WITH MULTIPLE-MYELOMA, Bone, 15(1), 1994, pp. 41-49
Authors:
CALLAERT S
RAVAUD P
VIENSBITKER C
DREYFUS F
HAZEBROUCQ G
AMOR B
BROUET JC
FERMAND JP
Citation: S. Callaert et al., COST OF INTENSIVE THERAPY FOLLOWED BY AUT OLOGOUS BLOOD STEM-CELL - TRANSPLANTATION IN MULTIPLE-MYELOMA, La Presse medicale, 23(15), 1994, pp. 694-698
Authors:
FERMAND JP
RAVAUD P
CHEVRET S
LEBLOND V
DIVINE M
DREYFUS F
BELANGER C
TROUSSARD X
MARIETTE X
BROUET JC
Citation: Jp. Fermand et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT) IN MULTIPLE-MYELOMA (MM) - PRELIMINARY-RESULTS OF A RANDOMIZED CLINICAL-TRIAL IN 167 PATIENTS, Blood, 84(10), 1994, pp. 10000535-10000535
Authors:
FERMAND JP
CHEVRET S
RAVAUD P
DIVINE M
LEBLOND V
DREYFUS F
MARIETTE X
BROUET JC
Citation: Jp. Fermand et al., HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF A PHASE-II TRIAL INVOLVING 63 PATIENTS, Blood, 82(7), 1993, pp. 2005-2009